Zobrazeno 1 - 5
of 5
pro vyhledávání: ''
Publikováno v:
Gut
The current coronavirus pandemic is an ongoing global health crisis due to covid-19, caused by severe acute respiratory syndrome coronavirus 2. Although covid-19 leads to little or mild flu-like symptoms in the majority of affected patients, the dise
Autor:
Walter, Reinisch, Sieglinde, Angelberger, Wolfgang, Petritsch, Olga, Shonova, Milan, Lukas, Simon, Bar-Meir, Alexander, Teml, Elke, Schaeffeler, Matthias, Schwab, Karin, Dilger, Roland, Greinwald, Ralph, Mueller, Eduard F, Stange, Klaus R, Herrlinger, Shmuel, Odes
Publikováno v:
Gut. 59:752-759
The aim of the study was to compare azathioprine versus mesalazine tablets for the prevention of clinical recurrence in patients with postoperative Crohn's disease (CD) with moderate or severe endoscopic recurrence.This was a 1 year, double-blind, do
Publikováno v:
Gut. 52(4)
A 57 year old Caucasian man presented with an eight week history of loose bowel motions 10 times daily, with blood, slime, and mucus. Sigmoidoscopy showed an abnormal vascular pattern and a granular mucosa. Rectal biopsy was reported histologically t
Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine
Autor:
I. Penman, Craig Williams, S. Banerjee, G. Cruikshank, S. Dover, Emad M. El-Omar, Kenneth E.L. McColl
Publikováno v:
Gut. 35(10)
The prevalence of IgG antibodies to Helicobacter pylori was examined in 110 patients with inflammatory bowel disease (IBD) (63 ulcerative colitis, 47 Crohn's disease) and compared with 100 age and sex matched control patients. The overall prevalence
Autor:
Andrew F. Muller, L Pee
Publikováno v:
Gut. 59:A63.2-A64
Introduction The Bowel Cancer Screening Programme (BCSP) was introduced in England in 2006, with the expectation that screening would be available throughout England for the 60–69 years of age cohort by the end of 2009. Our own Trust began screenin